Literature DB >> 28732259

Dravet syndrome: Characteristics, comorbidities, and caregiver concerns.

Nicole Villas1, Mary Anne Meskis2, Sue Goodliffe3.   

Abstract

The Dravet Syndrome Foundation (DSF) conducted the largest in-depth survey of parents and caregivers of patients with Dravet syndrome (DS) to date, in order to (1) identify top concerns among caregivers, (2) establish an approximate frequency of characteristics and comorbidities of DS beyond seizures, and (3) provide direction for clinicians and researchers looking to study the effects of DS on the patient and family unit. Two hundred fifty-six responses were received representing a patient age range of 9months to 32years with a median age group of 7-10years (IQR=8). In an open response, caregivers ranked speech/communication, impacts on siblings, and cognitive impairment as their top concerns after seizure control, and nearly two-thirds of caregivers reported having suffered from depression. Some characteristics of DS such as gait issues increased with patient age, while others, including photosensitivity, hypotonia, and ataxia, were present from a young age. Comorbidities such as sleep disturbances and cardiac abnormalities were more frequently reported than in previous studies and some (including bradycardia) were correlated with SCN1A mutation status. This survey supports the concept of Dravet syndrome as a disease of the central nervous system with far-reaching effects and highlights the importance of the patient voice in determining appropriate research objectives. While seizure frequency is a relatively well-understood objective, seizures represent only a portion of parent and caregiver concerns. Studying the characteristics of DS described herein may identify additional outcomes significant for research.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dravet Syndrome Foundation; Family impact; Patient-centered outcomes; SCN1A; Survey

Mesh:

Year:  2017        PMID: 28732259     DOI: 10.1016/j.yebeh.2017.06.031

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  28 in total

Review 1.  Treatment Strategies for Dravet Syndrome.

Authors:  Kelly G Knupp; Elaine C Wirrell
Journal:  CNS Drugs       Date:  2018-04       Impact factor: 5.749

2.  Circadian regulation of sleep in a pre-clinical model of Dravet syndrome: dynamics of sleep stage and siesta re-entrainment.

Authors:  Raymond E A Sanchez; Ivana L Bussi; Miriam Ben-Hamo; Carlos S Caldart; William A Catterall; Horacio O De La Iglesia
Journal:  Sleep       Date:  2019-12-24       Impact factor: 5.849

3.  NaV1.1 haploinsufficiency impairs glutamatergic and GABAergic neuron function in the thalamus.

Authors:  Carleigh Studtmann; Marek Ladislav; Mackenzie A Topolski; Mona Safari; Sharon A Swanger
Journal:  Neurobiol Dis       Date:  2022-02-24       Impact factor: 5.996

4.  Corticohippocampal circuit dysfunction in a mouse model of Dravet syndrome.

Authors:  Joanna Mattis; Ala Somarowthu; Kevin M Goff; Evan Jiang; Jina Yom; Nathaniel Sotuyo; Laura M Mcgarry; Huijie Feng; Keisuke Kaneko; Ethan M Goldberg
Journal:  Elife       Date:  2022-02-25       Impact factor: 8.140

5.  Anesthetic Management of Patient With Dravet Syndrome: A Case Report.

Authors:  Naohiro Ohshita; Kaname Tsuji; Hiroaki Yoshida; Hiroki Shibata; Yoshiko Matsuda; Yasuo M Tsutsumi; Yoshihiro Momota
Journal:  Anesth Prog       Date:  2019

Review 6.  Recent Advances in the Drug Treatment of Dravet Syndrome.

Authors:  Elaine C Wirrell; Rima Nabbout
Journal:  CNS Drugs       Date:  2019-09       Impact factor: 5.749

Review 7.  Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.

Authors:  K R Sabitha; Ashok K Shetty; Dinesh Upadhya
Journal:  Neurosci Biobehav Rev       Date:  2020-12-25       Impact factor: 8.989

8.  Dravet Syndrome-The Polish Family's Perspective Study.

Authors:  Justyna Paprocka; Anita Lewandowska; Piotr Zieliński; Bartłomiej Kurczab; Ewa Emich-Widera; Tomasz Mazurczak
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

Review 9.  A Role for Vasoactive Intestinal Peptide Interneurons in Neurodevelopmental Disorders.

Authors:  Kevin M Goff; Ethan M Goldberg
Journal:  Dev Neurosci       Date:  2021-04-01       Impact factor: 2.984

10.  Enhanced Synaptic Transmission in the Extended Amygdala and Altered Excitability in an Extended Amygdala to Brainstem Circuit in a Dravet Syndrome Mouse Model.

Authors:  Wen Wei Yan; Maya Xia; Jeremy Chiang; Alyssa Levitt; Nicole Hawkins; Jennifer Kearney; Geoffrey T Swanson; Dane Chetkovich; William P Nobis
Journal:  eNeuro       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.